Patents matching “ERNA”

US 8173424

Internalizing ErbB2 antibodies

The Regents of the University of California · Granted May 8, 2012 · Expires May 3, 2032

US 8110564

Bile acid or bile salt fatty acid conjugates

Galmed International Limited · Granted Feb 7, 2012 · Expires Feb 2, 2032

US 7968117

Externally triggered microcapsules

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Jun 28, 2011 · Expires Jun 23, 2031

US 7892554

Internalizing ErbB2 antibodies

The Regents of the University of California · Granted Feb 22, 2011 · Expires Feb 17, 2031

US 7892738

Pot1 alternative splicing variants

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

US 7871620

Immunoliposomes that optimize internationalization into target cells

The Regents of the University of California · Granted Jan 18, 2011 · Expires Jan 13, 2031

US 7834185

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Nov 16, 2010 · Expires Nov 11, 2030

US 7795300

External preparation for skin

KURARAY CO., LTD. · Granted Sep 14, 2010 · Expires Sep 9, 2030

US 7582736

Prostate cancer specific internalizing human antibodies

The Regents of the University of California · Granted Sep 1, 2009 · Expires Aug 27, 2029

US 7507407

Immunoliposomes that optimize internationalization into target cells

The Regents of the University of California · Granted Mar 24, 2009 · Expires Mar 19, 2029

US 7501403

Bile acid or bile salt fatty acid conjugates

Galmed International Limited · Granted Mar 10, 2009 · Expires Mar 5, 2029

US 7410958

Triterpene quaternary salts as biologically active surfactants

Regents of the University of Minnesota · Granted Aug 12, 2008 · Expires Aug 7, 2028

US 7335744

Prostate cancer specific internalizing human antibodies

The Regents of the California University · Granted Feb 26, 2008 · Expires Feb 21, 2028

US 7244826

Internalizing ERB2 antibodies

The Regents of the University of California · Granted Jul 17, 2007 · Expires Jul 12, 2027

US 7199114

Triterpene quaternary salts as biologically active surfactants

Regents of the University of Minnesota · Granted Apr 3, 2007 · Expires Mar 29, 2027

US 7135177

Immunoliposomes that optimize internalization into target cells

The Regents of the University of California · Granted Nov 14, 2006 · Expires Nov 9, 2026

US 7119103

β3-Adrenoreceptor agonists, agonist compositions and methods of using

Molecular Design International, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

US 7052703

T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 30, 2006 · Expires May 25, 2026

US 7045283

Methods of high-throughput screening for internalizing antibodies

The Regents of the University of California · Granted May 16, 2006 · Expires May 11, 2026

US 6939878

Deuterated rapamycin compounds, method and uses thereof

ISOTECHNIKA INTERNATIONAL INC. · Granted Sep 6, 2005 · Expires Sep 1, 2025

US 6919425

Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery

The Board of Regents of the University of Texas System · Granted Jul 19, 2005 · Expires Jul 14, 2025

US 6919357

α adrenergic agents

Molecular Design International, Inc. · Granted Jul 19, 2005 · Expires Jul 14, 2025

US 6884413

Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (GCS)

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 26, 2005 · Expires Apr 21, 2025

US 6884429

Medical devices incorporating deuterated rapamycin for controlled delivery thereof

ISOTECHNIKA INTERNATIONAL INC. · Granted Apr 26, 2005 · Expires Apr 21, 2025